According to Future Market Insights research, during the projected period, the global market is expected to grow at a CAGR of 7.2%. The market value is projected to increase from US$ 210.8 million in 2023 to US$ 421.4 million by 2033. The global market was valued at US$ 200.6 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.3% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 200.6 Million |
| Market Value 2023 | US$ 210.8 Million |
| Market Value 2033 | US$ 421.4 Million |
| CAGR 2023 to 2033 | 7.2% |
| Share of Top 5 Countries | 58.4% |
| Key Players | The key players in the Global Market Are Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems; Inc. and Primerdesign Ltd. |
The process of RNA extraction, also known as RNA isolation, involves the separation of RNA from a cell. The utilization of this technique is advantageous in various applications such as gene expression analysis, pathogen identification, and classification. Due to its reliance on nucleic acid detection, this technique exhibits high levels of accuracy, reproducibility, and versatility.
The RNA of a living cell, regardless of its origin from an animal, plant, human, bacteria, or virus, is a valuable source of information regarding genetic material. As such, it is a crucial component of gene expression studies. The RNA lysis buffer is known to facilitate the lysis of the cell wall/membrane, whereas the utilization of organic solvents, such as phenol-chloroform, is commonly employed to effectuate the separation of RNA via centrifugation. The utilization of Phenol: Chloroform: Isoamyl alcohol in conjunction with centrifugation results in the formation of three distinct layers. These layers consist of the lower organic layer, the middle layer containing DNA and protein, and the upper aqueous layer containing RNA. The upper aqueous phase is carefully collected and subsequently subjected to precipitation, washing, and dissolution in RNase-free water.
RNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. The rising incidence of cancer globally is resulting in the need for advanced RNA extraction kits, which in turn is expected to drive the market in the upcoming years.
Overall, the increasing adoption of the latest technologies such as mutation analysis and comparative genomic hybridization, the prevalence of cancer and the need for advanced genomic techniques, this factors will boost the market in the future.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the global market grew at a CAGR of 8.6% between 2017 and 2022. The global market contributes 16.5% revenue share to the global extraction kit market valued at US$ 1.2 billion in 2022.
The accurate detection and monitoring of viral RNA are essential for understanding the prevalence, transmission, and control of viral diseases. Thus, RNA extraction kits play a critical role in diagnosing viral infections and conducting epidemiological surveillance.
Technological advancements, such as real-time polymerase chain reaction (PCR), real-time reverse transcription–polymerase chain (RT-PCR), and next-generation sequencing, have revolutionized molecular diagnostics. The increasing adoption of molecular diagnostic methods drives the demand for the global market.
During outbreaks and pandemics, the rapid and accurate detection of viral RNA is crucial for effective public health response. Extraction kits enable healthcare professionals and researchers to quickly identify the presence of viral pathogens, assess the extent of the outbreak, and implement appropriate control measures.
Viral RNA extraction kits are indispensable tools for researchers studying viral diseases. These kits enable the isolation and analysis of viral RNA, providing insights into viral pathogenesis, genetic diversity, and potential therapeutic targets. Advancements in research contribute to the development of new and improved extraction kits.
Considering this, FMI expects the global market to grow at a CAGR of 7.2% through 2023 to 2033.
In recent years, government agencies in the Asia-Pacific and the Middle East have easily encouraged manufacturers to drive industrial growth in the healthcare and bio-pharmacy industries. Key players can take advantage of regulatory scenarios to grow in the market.
For example, developing countries in the Asia-Pacific region, such as India, have lifted export restrictions on diagnostic kits and reagents, including equipment such as extraction kits and systems used to detect coronavirus infections.
In the COVID-19 pandemic, the life sciences division played a crucial role. Traditional competitors banded together to speed up research and develop the fastest new vaccines to combat the worldwide issue. The science, technology, and innovation (STI) response to COVID-19 is based on collaboration, with national and international collaborative platforms for technology, revolutionizing vaccine design and production.
Favourable government policies and rising research initiatives, collaboration activities amongst countries like the U.S. is supposed to set out promising open doors for key market players.
These factors are expected to provide growth opportunities to key players in the market over the forecast period.
Principal Consultant
The promotion of a mainstream biotech industry by several governments, akin to the extraction kit model, has encountered sluggish progress. It has been observed that the growth and progress of various regions are contingent upon the availability of proficient experts. A significant disparity has been observed by numerous organizations between proficient experts and the present labour pool. The dearth of seasoned professionals has impeded market expansion in numerous developing nations.
Changing regulatory dynamics is one of the restraining factors for the market such as each country's regulatory authorities and procedures may differ. While many follow the standards of large countries, such as the United States Food and Drug Administration (FDA), others have their approval timelines. In such circumstances, one provider is unable to introduce new or better items until all extraction kits have been validated.
Before beginning the distribution of their product or equipment, companies must wait for all regulatory approvals to be received. Validation is not necessary for US FDA-approved kits, however, it is essential for CE-IVD authorized/non-US FDA approved/indigenous kits, which require batch testing.
These factors are expected to hamper the revenue growth of the extraction kit market over the forecast period.
In the United States, the adoption of extraction kits is more due to extensive research and development activities in the fields of molecular biology.
The United States has a robust biotechnology and pharmaceutical industry that heavily relies on RNA extraction kits. Companies involved in drug discovery, diagnostic development, and therapeutic research require high-quality RNA samples for their research and development pipelines.
During the projected period, the U.S. market accounted for around 31.9% of the global market share in 2022.
Due to the advanced pharmaceutical and biotechnological industry in the U.S., there will be increasing demand for RNA extraction kits, which will drive the expansion of the market.
Germany dominated the European market and accounted for 7.5% of the global market share in the year 2022.
Germany has a strong research and development landscape, with renowned research institutions and universities engaged in virology research. Researchers studying viral diseases rely on extraction kits to isolate and analyze viral RNA for understanding the pathogenesis, developing vaccines, and designing therapeutic strategies.
Due to the strong research and development and German government support and funding, there will be demand for RNA extraction kits, which will drive the expansion of the market.
China dominated the East Asia market and accounted for around 49.6% of the regional market share in the year 2022.
China has the world's largest population, which increases the demand for the global market for diagnosing and monitoring viral infections. The country's focus on public health and disease control requires reliable tools for viral RNA detection and surveillance.
Global market demand is rising as more individuals become aware of the test and are thus more likely to adapt to the testing procedure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The nasal washes and swab segment held significant chunk of about 37.9% in global market by the end of 2022.
Nasal washes and swabs allow for direct sampling of the respiratory tract, where many respiratory viruses, including SARS-CoV-2 (the virus causing COVID-19), primarily infect. These sample types can capture the virus directly from the nasal cavity, nasopharynx, or oropharynx, providing a representative sample of the viral load present in the respiratory system.
Non-invasive collection and high viral load in respiratory secretions are one of the reasons for the increasing adoption of nasal swabs.
Overall, nasal washes and the swab is used as sample type for RNA extraction due to their high specificity.
The disease diagnosis segment accounted for a revenue share of 37.1% in the global market at the end of 2022.
The utilization of viral RNA extraction kits is crucial in the identification of viral infections. It has been observed that various viruses, including but not limited to SARS-CoV-2 (COVID-19), influenza viruses, and respiratory syncytial virus (RSV), possess RNA as their genetic material.
By isolating and extracting viral RNA from patient samples, it becomes possible to detect the presence of the virus and diagnose the corresponding viral infection.
Overall, disease diagnosis offers monitoring of treatment efficiency, making it the most significant sample for this segment.
The diagnostic laboratories segment accounted for a revenue share of 30.1% in the global market at the end of 2022.
Diagnostic laboratories are essential for the global market as they ensure accurate diagnosis, maintain quality standards, validate tests, handle high testing volumes, provide expert interpretation, and contribute to collaborative networks for effective disease management.
Overall, diagnostic Laboratories offer convenient testing options, making them the dominant end user for this segment.
The viral RNA extraction kit market's major companies are concentrating on diversifying their product offerings to boost their market share and establish a presence in developing nations. Pricing strategies, market strategies, technology improvements, regulatory compliance, and acquisition and distribution agreements with other firms to extend their company are the main tactics used by manufacturers to acquire a competitive advantage in the market.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the global market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Sample Type, Application, End User, Region |
| Key Companies Profiled |
Bio Rad Laboratories Inc.; ThermoFisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc.; Primerdesign Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The projected CAGR of the viral RNA extraction kit market by 2033 is 7.2%.
The projected market value by 2033 is US$ 421.4 million.
The market is estimated to secure a valuation of US$ 210.8 million in 2023.
The health and diagnostic industry is the leading consumer of the market.
The increasing prevalence of viral infections is the key opportunity in the kit market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Technological Roadmap 4.3. Regulatory Scenario 4.4. Regional PESTLE Analysis 4.5. Porter’s Analysis 4.6. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure 5.1.2. Global Extraction Kits Market 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increasing Treatment Seeking Rate 5.2.3. New Test Type Launches/Approvals 5.2.4. Increasing Incidence of Infectious diseases 5.2.5. Government Initiatives to Combat Cancer 5.2.6. Companies Increasingly Spending on R&D and Focus on Innovation 5.2.7. Collaborations and Agreements between Manufacturers 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume Analysis, 2017 to 2022 6.2. Current and Future Market Volume Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market – Pricing Assessment 7.1. Regional Pricing Analysis 7.2. Global Average Pricing Analysis Benchmark 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Sample Type, 2023 to 2033 9.3.1. Nasal Washes and Swab 9.3.2. Sputum 9.3.3. Saliva 9.3.4. Fecal & Stool 9.3.5. Urine 9.3.6. Blood 9.3.7. Tissues 9.3.8. Others 9.4. Market Attractiveness Analysis by Sample Type 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033 10.3.1. Disease Diagnosis 10.3.2. Drug Discovery 10.3.3. Cancer Research 10.3.4. cDNA Library 10.3.5. Others 10.4. Market Attractiveness Analysis by Application 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033 11.3.1. Hospitals 11.3.2. Academic & Research Institutes 11.3.3. Pharmaceutical & Biotechnology Companies 11.3.4. Clinical Research Organizations 11.3.5. Diagnostic Laboratories 11.3.6. Forensic Labs 11.3.7. Others 11.4. Market Attractiveness Analysis by End User 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East & Africa 12.4. Market Attractiveness Analysis by Countries 13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 13.3.1. By Countries 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Sample Type 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Countries 13.4.2. By Sample Type 13.4.3. By Application 13.4.4. By End User 13.5. Drivers & Restraints Impact Analysis 13.6. Country-wise Analysis 13.6.1. U.S. Market Analysis 13.6.1.1. Introduction 13.6.1.2. Market Analysis and Forecast by Market Taxonomy 13.6.1.2.1. By Sample Type 13.6.1.2.2. By Application 13.6.1.2.3. By End User 13.6.2. Canada Market Analysis 13.6.2.1. Introduction 13.6.2.2. Market Analysis and Forecast by Market Taxonomy 13.6.2.2.1. By Sample Type 13.6.2.2.2. By Application 13.6.2.2.3. By End User 14. Latin America Global Viral Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 14.3.1. By Countries 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Sample Type 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Countries 14.4.2. By Sample Type 14.4.3. By Application 14.4.4. By End User 14.5. Drivers & Restraints Impact Analysis 14.6. Country-wise Analysis 14.6.1. Brazil Market Analysis 14.6.1.1. Introduction 14.6.1.2. Market Analysis and Forecast by Market Taxonomy 14.6.1.2.1. By Sample Type 14.6.1.2.2. By Application 14.6.1.2.3. By End User 14.6.2. Mexico Market Analysis 14.6.2.1. Introduction 14.6.2.2. Market Analysis and Forecast by Market Taxonomy 14.6.2.2.1. By Sample Type 14.6.2.2.2. By Application 14.6.2.2.3. By End User 14.6.3. Argentina Market Analysis 14.6.3.1. Introduction 14.6.3.2. Market Analysis and Forecast by Market Taxonomy 14.6.3.2.1. By Sample Type 14.6.3.2.2. By Application 14.6.3.2.3. By End User 15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.3.1. By Countries 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Sample Type 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Countries 15.4.2. By Sample Type 15.4.3. By Application 15.4.4. By End User 15.5. Drivers & Restraints Impact Analysis 15.6. Country-wise Analysis 15.6.1. Germany Market Analysis 15.6.1.1. Introduction 15.6.1.2. Market Analysis and Forecast by Market Taxonomy 15.6.1.2.1. By Sample Type 15.6.1.2.2. By Application 15.6.1.2.3. By End User 15.6.2. Italy Market Analysis 15.6.2.1. Introduction 15.6.2.2. Market Analysis and Forecast by Market Taxonomy 15.6.2.2.1. By Sample Type 15.6.2.2.2. By Application 15.6.2.2.3. By End User 15.6.3. France Market Analysis 15.6.3.1. Introduction 15.6.3.2. Market Analysis and Forecast by Market Taxonomy 15.6.3.2.1. By Sample Type 15.6.3.2.2. By Application 15.6.3.2.3. By End User 15.6.4. U.K. Market Analysis 15.6.4.1. Introduction 15.6.4.2. Market Analysis and Forecast by Market Taxonomy 15.6.4.2.1. By Sample Type 15.6.4.2.2. By Application 15.6.4.2.3. By End User 15.6.5. Spain Market Analysis 15.6.5.1. Introduction 15.6.5.2. Market Analysis and Forecast by Market Taxonomy 15.6.5.2.1. By Sample Type 15.6.5.2.2. By Application 15.6.5.2.3. By End User 15.6.6. BENELUX Market Analysis 15.6.6.1. Introduction 15.6.6.2. Market Analysis and Forecast by Market Taxonomy 15.6.6.2.1. By Sample Type 15.6.6.2.2. By Application 15.6.6.2.3. By End User 15.6.7. Russia Market Analysis 15.6.7.1. Introduction 15.6.7.2. Market Analysis and Forecast by Market Taxonomy 15.6.7.2.1. By Sample Type 15.6.7.2.2. By Application 15.6.7.2.3. By End User 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Countries 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Malaysia 16.3.1.4. Thailand 16.3.1.5. Rest of South Asia 16.3.2. By Sample Type 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Countries 16.4.2. By Sample Type 16.4.3. By Application 16.4.4. By End User 16.5. Drivers & Restraints Impact Analysis 16.6. Country-wise Analysis 16.6.1. India Market Analysis 16.6.1.1. Introduction 16.6.1.2. Market Analysis and Forecast by Market Taxonomy 16.6.1.2.1. By Sample Type 16.6.1.2.2. By Application 16.6.1.2.3. By End User 16.6.2. Indonesia Market Analysis 16.6.2.1. Introduction 16.6.2.2. Market Analysis and Forecast by Market Taxonomy 16.6.2.2.1. By Sample Type 16.6.2.2.2. By Application 16.6.2.2.3. By End User 16.6.3. Malaysia Market Analysis 16.6.3.1. Introduction 16.6.3.2. Market Analysis and Forecast by Market Taxonomy 16.6.3.2.1. By Sample Type 16.6.3.2.2. By Application 16.6.3.2.3. By End User 16.6.4. Thailand Market Analysis 16.6.4.1. Introduction 16.6.4.2. Market Analysis and Forecast by Market Taxonomy 16.6.4.2.1. By Sample Type 16.6.4.2.2. By Application 16.6.4.2.3. By End User 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Countries 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Sample Type 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Countries 17.4.2. By Sample Type 17.4.3. By Application 17.4.4. By End User 17.5. Drivers & Restraints Impact Analysis 17.6. Country-wise Analysis 17.6.1. China Market Analysis 17.6.1.1. Introduction 17.6.1.2. Market Analysis and Forecast by Market Taxonomy 17.6.1.2.1. By Sample Type 17.6.1.2.2. By Application 17.6.1.2.3. By End User 17.6.2. Japan Market Analysis 17.6.2.1. Introduction 17.6.2.2. Market Analysis and Forecast by Market Taxonomy 17.6.2.2.1. By Sample Type 17.6.2.2.2. By Application 17.6.2.2.3. By End User 17.6.3. South Korea Market Analysis 17.6.3.1. Introduction 17.6.3.2. Market Analysis and Forecast by Market Taxonomy 17.6.3.2.1. By Sample Type 17.6.3.2.2. By Application 17.6.3.2.3. By End User 18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 18.3.1. By Countries 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Sample Type 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Countries 18.4.2. By Sample Type 18.4.3. By Application 18.4.4. By End User 18.5. Drivers & Restraints Impact Analysis 18.6. Country-wise Analysis 18.6.1. Australia Market Analysis 18.6.1.1. Introduction 18.6.1.2. Market Analysis and Forecast by Market Taxonomy 18.6.1.2.1. By Sample Type 18.6.1.2.2. By Application 18.6.1.2.3. By End User 18.6.2. New Zealand Market Analysis 18.6.2.1. Introduction 18.6.2.2. Market Analysis and Forecast by Market Taxonomy 18.6.2.2.1. By Sample Type 18.6.2.2.2. By Application 18.6.2.2.3. By End User 19. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 19.3.1. By Countries 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. South Africa 19.3.1.4. Rest of MEA 19.3.2. By Sample Type 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Countries 19.4.2. By Sample Type 19.4.3. By Application 19.4.4. By End User 19.5. Drivers & Restraints Impact Analysis 19.6. Country-wise Analysis 19.6.1. GCC Countries Market Analysis 19.6.1.1. Introduction 19.6.1.2. Market Analysis and Forecast by Market Taxonomy 19.6.1.2.1. By Sample Type 19.6.1.2.2. By Application 19.6.1.2.3. By End User 19.6.2. Türkiye Market Analysis 19.6.2.1. Introduction 19.6.2.2. Market Analysis and Forecast by Market Taxonomy 19.6.2.2.1. By Sample Type 19.6.2.2.2. By Application 19.6.2.2.3. By End User 19.6.3. South Africa Market Analysis 19.6.3.1. Introduction 19.6.3.2. Market Analysis and Forecast by Market Taxonomy 19.6.3.2.1. By Sample Type 19.6.3.2.2. By Application 19.6.3.2.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players (%) 20.3. Market Concentration 21. Competition Analysis 21.1. Competition Dashboard 21.2. Key Development Analysis 21.3. Branding and Promotional Strategies, By key players 21.4. Competition Deep Dive 21.4.1. Bio-Rad Laboratories Inc. 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. SWOT Analysis 21.4.1.5. Key Developments 21.4.1.6. Sales Footprint 21.4.1.7. Strategy Overview 21.4.1.7.1. Marketing Strategy 21.4.1.7.2. Product Strategy 21.4.1.7.3. Channel Strategy 21.4.2. ThermoFisher Scientific 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. SWOT Analysis 21.4.2.5. Key Developments 21.4.2.6. Sales Footprint 21.4.2.7. Strategy Overview 21.4.2.7.1. Marketing Strategy 21.4.2.7.2. Product Strategy 21.4.2.7.3. Channel Strategy 21.4.3. Promega Corporation 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. SWOT Analysis 21.4.3.5. Key Developments 21.4.3.6. Sales Footprint 21.4.3.7. Strategy Overview 21.4.3.7.1. Marketing Strategy 21.4.3.7.2. Product Strategy 21.4.3.7.3. Channel Strategy 21.4.4. Agilent Technologies 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. SWOT Analysis 21.4.4.5. Key Developments 21.4.4.6. Sales Footprint 21.4.4.7. Strategy Overview 21.4.4.7.1. Marketing Strategy 21.4.4.7.2. Product Strategy 21.4.4.7.3. Channel Strategy 21.4.5. Bioneer Corporation 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. SWOT Analysis 21.4.5.5. Key Developments 21.4.5.6. Sales Footprint 21.4.5.7. Strategy Overview 21.4.5.7.1. Marketing Strategy 21.4.5.7.2. Product Strategy 21.4.5.7.3. Channel Strategy 21.4.6. PerkinElmer Inc. 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. SWOT Analysis 21.4.6.5. Key Developments 21.4.6.6. Sales Footprint 21.4.6.7. Strategy Overview 21.4.6.7.1. Marketing Strategy 21.4.6.7.2. Product Strategy 21.4.6.7.3. Channel Strategy 21.4.7. LGC Biosearch Technologies 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. SWOT Analysis 21.4.7.5. Key Developments 21.4.7.6. Sales Footprint 21.4.7.7. Strategy Overview 21.4.7.7.1. Marketing Strategy 21.4.7.7.2. Product Strategy 21.4.7.7.3. Channel Strategy 21.4.8. Qiagen 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. SWOT Analysis 21.4.8.5. Key Developments 21.4.8.6. Sales Footprint 21.4.8.7. Strategy Overview 21.4.8.7.1. Marketing Strategy 21.4.8.7.2. Product Strategy 21.4.8.7.3. Channel Strategy 21.4.9. General Biosystems 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. SWOT Analysis 21.4.9.5. Key Developments 21.4.9.6. Sales Footprint 21.4.9.7. Strategy Overview 21.4.9.7.1. Marketing Strategy 21.4.9.7.2. Product Strategy 21.4.9.7.3. Channel Strategy 21.4.10. Takara Bio Inc. 21.4.10.1. Overview 21.4.10.2. Product Portfolio 21.4.10.3. Key Financials 21.4.10.4. SWOT Analysis 21.4.10.5. Key Developments 21.4.10.6. Sales Footprint 21.4.10.7. Strategy Overview 21.4.10.7.1. Marketing Strategy 21.4.10.7.2. Product Strategy 21.4.10.7.3. Channel Strategy 21.4.11. Roche Life Science 21.4.11.1. Overview 21.4.11.2. Product Portfolio 21.4.11.3. Key Financials 21.4.11.4. SWOT Analysis 21.4.11.5. Key Developments 21.4.11.6. Sales Footprint 21.4.11.7. Strategy Overview 21.4.11.7.1. Marketing Strategy 21.4.11.7.2. Product Strategy 21.4.11.7.3. Channel Strategy 21.4.12. GeneReach Biotechnology Corporation 21.4.12.1. Overview 21.4.12.2. Product Portfolio 21.4.12.3. Key Financials 21.4.12.4. SWOT Analysis 21.4.12.5. Key Developments 21.4.12.6. Sales Footprint 21.4.12.7. Strategy Overview 21.4.12.7.1. Marketing Strategy 21.4.12.7.2. Product Strategy 21.4.12.7.3. Channel Strategy 21.4.13. Merck Millipore 21.4.13.1. Overview 21.4.13.2. Product Portfolio 21.4.13.3. Key Financials 21.4.13.4. SWOT Analysis 21.4.13.5. Key Developments 21.4.13.6. Sales Footprint 21.4.13.7. Strategy Overview 21.4.13.7.1. Marketing Strategy 21.4.13.7.2. Product Strategy 21.4.13.7.3. Channel Strategy 21.4.14. BioFire Defense LLC 21.4.14.1. Overview 21.4.14.2. Product Portfolio 21.4.14.3. Key Financials 21.4.14.4. SWOT Analysis 21.4.14.5. Key Developments 21.4.14.6. Sales Footprint 21.4.14.7. Strategy Overview 21.4.14.7.1. Marketing Strategy 21.4.14.7.2. Product Strategy 21.4.14.7.3. Channel Strategy 21.4.15. Akonni Biosystems, Inc. 21.4.15.1. Overview 21.4.15.2. Product Portfolio 21.4.15.3. Key Financials 21.4.15.4. SWOT Analysis 21.4.15.5. Key Developments 21.4.15.6. Sales Footprint 21.4.15.7. Strategy Overview 21.4.15.7.1. Marketing Strategy 21.4.15.7.2. Product Strategy 21.4.15.7.3. Channel Strategy 21.4.16. Primerdesign Ltd. 21.4.16.1. Overview 21.4.16.2. Product Portfolio 21.4.16.3. Key Financials 21.4.16.4. SWOT Analysis 21.4.16.5. Key Developments 21.4.16.6. Sales Footprint 21.4.16.7. Strategy Overview 21.4.16.7.1. Marketing Strategy 21.4.16.7.2. Product Strategy 21.4.16.7.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Viral RNA Extraction Kit Market
